PipelinePharma Logo

ibuprofen lysine Tablets 342 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #36540

Established in January 2010, this manufacturer specializes in the contract manufacturing of oral solid dosage forms for both pharmaceuticals and nutraceuticals. As a CTD dossier owner and manufacturer, it holds GMP approvals, ensuring compliance with international quality standards. The manufacturer operates advanced production lines for tablets, capsules, and sachets, adhering to stringent GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed in various countries worldwide. With a dedicated team experienced in formulation development, the manufacturer is committed to delivering high-quality and regulatory-compliant products

Ibuprofen lysine Manufacturers

Markets of interest

Ibuprofen lysine is a non-steroidal anti-inflammatory drug. The substance is available for sale in the form of tablets, film-coated tablets, granules for oral solution, capsules, gel, oral solution, solution for injection, from manufacturers in various countries including Y. The drug is provided by a wide range of Ibuprofen lysine suppliers from various countries including the Y, Y, and Y. Mostly due to the availability of raw materials for the manufacturing process and low labor costs, the leading Ibuprofen lysine manufacturers and distributors are based in China and North Korea.

Licensing and brand names

Ibuprofen lysine was patented in 1961 and launched against rheumatoid arthritis in the UK in 1969 and the USA in 1974. The medication was approved in 2006 in the U.S by the FDA for the closure of patent ductus arteriosus in premature infants weighing between 500 and 1,500 grams, in newborns younger than 32 weeks gestational age when a usual treatment like fluid restriction, diuretics, and respiratory support is not effective. The medication is presently approved in many countries and is available in both generic and trade name versions. The medication is marketed under a big number of trade names including Neoprofen, Actiprofen, Adex, Algoflex and etc. . One of the most popular branded versions of Ibuprofen lysine is manufactured and supplied by the Chinese pharmaceutical company Shandong Octagon Chemicals Limited. Other manufacturing companies and distributors from India and Germany have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with Ibuprofen lysine as an active ingredient.

Target supply price

The wholesale acquisition cost of NeoProfen intravenous solution (10 mg/mL) is around $2,810 for a supply of 6 milliliters. The retail price of 342 mg of substance contained in 16 tablets in Europe reaches €3.8 EUR. The medication wholesale prices and commercial terms can vary depending on the supplier. The medication wholesale prices and commercial terms can vary depending on the supplier.

Information from manufacturers

We provide a detailed list of the Ibuprofen lysine manufacturers and suppliers that you are looking for. You can also find the dossier status of Ibuprofen lysine and the GMP approvals of the different variants of the medication. The product description of all Ibuprofen lysine suppliers contains essential information about the medication you order including clinical data, stability zones, and a list of countries where Ibuprofen lysine is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms as well as delivery terms. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Follicle-stimulating hormone suppliers and distributors enter our online marketplace, offering you a risk-free global B2B pharmaceutical sales platform.